For decades now, pharmaceuticals have been developed and designed to be stable as possible to avoid degradation before reaching their eventual recipient. The next 10 - 15 years could be an era of great progress and growth. In this period, we have the technological, financial and human resources to raise living standards across the world. Good policies that support investment and innovation can further reduce poverty and hunger, make fast-growing cities economically vibrant and socially inclusive, and restore and protect the world’s natural environments.

References

1. Souza GF and BS Sami. “Waste pharmaceutical and Green Pharmaceutical Supply Chain (GPSC)”. Paper presented during the International Conference on: Communication, Management and Information Technology (ICCMIT’18), Madrid, Spain, Acceptance letter, Technical Paper (2018).
2. Melo SRDO., et al. “Advice on Degradation Products in Pharmaceuticals: A Toxicological Evaluation”. PDA Journal of Pharmaceutical Science and Technology3 (2014): 221-238.
3. Stanimirovic V., et al. “Importance of pharmaco-toxicological evaluation of increased drug impurities and preserving drug quality and patient’s safety”. Basic and Clinical Pharmacology and Toxicology 107 (2010): 109.
4. Souza GF. “Environmental assessment in the cooperatives of recyclable materials”. Doctoral Thesis, Faculdade de Medicina, Universidade de São Paulo; São Paulo, Brazil (2015).
5. Rastogi T., et al. “Designing green derivatives of β-blocker Metoprolol: A tiered approach for green and sustainable pharmacy and chemistry”. Chemosphere 111 (2014): 493-499.
6. Cherkasov A., et al. “QSAR modeling: Where have you been? Where are you going to?” Journal of Medicinal Chemistry 12 (2014): 4977-5010.
7. Gad SC. “QSAR”. In Encyclopedia of Toxicology: Third Edition (2014): 1-9.
8. Souza GF and BS Sami. “Waste pharmaceutical potential environmental risks”. International Conference on Communication, Management and Information Technology (ICCMIT’18), Madrid, Spain, Acceptance letter, Technical Paper (2018).
9. Charde MS., et al. “Review: Development of forced degradation studies of drugs”. International Journal of Advances in Pharmaceutics3 (2013): 1-6.
10. Srivastava RK. “An updated review: Forced degradation study”. World Journal of Pharmacy and Pharmaceutical Sciences (2017): 709-726.
11. Kragelj Lapanja N., et al. “Theoretical Purge Factor Determination as a Control Strategy for Potential Mutagenic Impurities in the Synthesis of Drug Substances”. Acta Chimica Slovenica 1 (2017): 1-14.
12. Occupational Toxicology, Second Edition (2018).
13. Wattenberg EV. “Occupational Toxicology”. In Encyclopedia of Toxicology: Third Edition (2014): 643-647.
14. Souza GF., et al. “Occupational exposure to mercury in cooperatives of recyclable materials the metropolitan region of São Paulo”. Ciência and Saúde Coletivas (2017).
15. PK Sethy and SK Behera. “Detection of Coronavirus Disease (COVID-19) Based on Deep Features”. Engineering (2020).

Citation

Citation: Gisele Ferreira De Souza. “Pharmaceutical Industry Report".Acta Scientific Nutritional Health 4.9 (2020): 75-77.

Copyright

Copyright: © 2020 Gisele Ferreira De Souza. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.